Regulatory

Safety substantiation requirements for finished cosmetic products to comply with The Modernization of Cosmetics Regulations Act (MoCRA).

ADM announced that its spore-forming probiotic DE111 (Bacillus subtilis) has received official approval from the Therapeutic Goods Administration (TGA), which is a part of the Australian Department of Health.

The authorization by the EU allows the use of ampli-D at a maximum daily dose of 10 µg in children over 11 years old and adults including pregnant and lactating women, and a maximum daily dose of 5 µg for children aged 3-10.

New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.

According to Keraplast, independent tests show that its keratin products have trace nitrosamine levels of < 1 ppb, while the maximum allowed is 50 ppb.

The latest updates in the efforts of the Natural Products Association and the Council for Responsible Nutrition to sue New York state for its law banning the sale of weight management and muscle building supplements to minors.

ADM has announced that its spore-forming probiotic called DE111 has been approved by China’s National Health Commission.

The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.

The first set of guidelines are for the formulation, labeling, and packaging of melatonin-containing supplements, and the second is relates to the labeling of gummy dietary supplements.

The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”

Both NPA and CRN have filed lawsuits against the state to block to law, which is supposed to go into effect on April 22, 2024.

FDA has published a draft guidance on new dietary ingredient notification master files.

Nutritional Outlook caught up with Steve Mister, president and CEO of the Council for Responsible Nutrition at Natural Products Expo West to discuss FDA's FY25 Legislative Proposals related to dietary supplements.

Nutritional Outlook caught up with the president and CEO of the Council for Responsible Nutrition at Natural Products Expo West 2024, and he told us his takeaways from the final NDIN guidance.

Nutritional Outlook caught up with CRN's president and CEO Steve Mister at Expo West 2024 to learn more about the organization's lawsuit.

U.S. Senator Dick Durbin (D-IL) has sent a letter to four industry trade groups urging the association’s support in Congress’s efforts to modernize the Dietary Supplement Health and Education Act (DSHEA).

CRN is suing New York State for the passage of a law that prohibits the sale of dietary supplements marketed for weight management and muscle building to minors.

Without proper enforcement, the NDI notification process does not effectively safeguard consumers, nor does it incentivize manufacturers to invest the time and money to submit.

The U.S. Food and Drug Administration published a final guidance for industry titled “Dietary Supplements: New Dietary Ingredient Notification Procedures and Timeframes: Guidance for Industry.”

Foreign regulation and consumer sentiment may be pushing manufacturers away from titanium dioxide.

Ahead of Expo West 2024, TriNutra has announced a recent U.S. patent for the unique composition of its branded ingredients, ThymoQuin, B’utyQuin, and ThymoQuin-OCare.

According to Alkemist’s 2023 data, 47% of samples had levels of inorganic bromide above USP <561> limits.

This is an annual event in which industry stakeholders can meet with members of Congress and explain how public policies are impacting their businesses and consumers.

Scott Mazza breaks down the industry's top regulatory priorities related to CBD.

In this Q&A, experts look ahead at the opportunities and challenges the new year brings to contract manufacturing.

The joint venture between Cargill and dms-firmenich, called Avansya, has announced that EverSweet stevia sweetener has received a positive safety opinion from the European Food Safety Authority and the UK Food Standards Agency.

Curcumin C3 Reduct has earned approval by the National Health Surveillance Agency in Brazil for inclusion on ANVISA’s IN28 list, which allows the product to be introduced and commercialized in food and supplements in Brazil.

According to Ethical Naturals, the approval was the result of 18 months of work by the company and Transchem, its Australian partner and exclusive distributor of AlphaWave in the country.